Advanced Solid Tumor Cancer Clinical Trials

9 recruitingLast updated: June 17, 2026

There are 9 actively recruiting advanced solid tumor cancer clinical trials across 9 countries. Studies span Phase 1, Phase 2, Not Applicable. Top locations include Shanghai, Shanghai Municipality, China, Durham, North Carolina, United States, Beijing, China. Updated daily from ClinicalTrials.gov.


Advanced Solid Tumor Cancer Trials at a Glance

9 actively recruiting trials for advanced solid tumor cancer are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Phase 1 with 6 trials, with the heaviest enrollment activity in Shanghai, Durham, and Beijing. Lead sponsors running advanced solid tumor cancer studies include HC Biopharma Inc., Calico Life Sciences LLC, and BioNTech SE.

Browse advanced solid tumor cancer trials by phase

Treatments under study

About Advanced Solid Tumor Cancer Clinical Trials

Looking for clinical trials for Advanced Solid Tumor Cancer? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Advanced Solid Tumor Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Advanced Solid Tumor Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer

Advanced Solid Tumor CancerGlioblastomaSmall Cell Lung Cancer Extensive Stage+2 more
University of Colorado, Boulder250 enrolled2 locationsNCT07636200
Recruiting
Phase 1

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Advanced Solid Tumor Cancer
Calico Life Sciences LLC248 enrolled30 locationsNCT04777994
Recruiting
Phase 1Phase 2

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

Advanced Solid Tumor Cancer
BioNTech SE533 enrolled5 locationsNCT07455734
Recruiting
Phase 1

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors

Advanced Solid Tumor Cancer
HC Biopharma Inc.331 enrolled1 locationNCT07477743
Recruiting
Phase 1

X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma

Advanced Solid Tumor Cancer
Immunolight, LLC52 enrolled4 locationsNCT04389281
Recruiting
Phase 2

Phase II Study of LM-24C5

Advanced Solid Tumor Cancer
LaNova Medicines Limited130 enrolled2 locationsNCT07387081
Recruiting
Phase 1

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer

Advanced Solid Tumor Cancer
HC Biopharma Inc.328 enrolled1 locationNCT07381829
Recruiting
Phase 2

Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies

Antibody-drug ConjugatesAdvanced Solid Tumor CancerUrachal Cancer
Sheng Zhang90 enrolled1 locationNCT07309770
Recruiting
Phase 1

Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors

Advanced Solid Tumor Cancer
Peking University10 enrolled2 locationsNCT07139067